← Back to guidelines
Cardiology11 papers

Hepatorenal syndrome with acute kidney injury

Last edited: 4/22/2026

Overview

Hepatorenal syndrome (HRS) with acute kidney injury (AKI) is a functional form of renal failure characterized by progressive renal hypoperfusion and tubular dysfunction, commonly seen in patients with advanced liver disease, particularly cirrhosis 12.

Diagnosis

  • Clinical Presentation: Typically includes ascites, hepatic encephalopathy, and signs of circulatory dysfunction 12.
  • Laboratory Findings: Elevated creatinine, low urine sodium concentration, and absence of intrinsic kidney disease markers 12.
  • Imaging: Abnormal chest X-rays may show pleural effusion or parenchymal infiltrates, though these are more indicative of postcardiac injury syndrome rather than HRS 2.
  • Renal Biomarkers: Elevated fractional excretion of sodium (FENa) and decreased renal perfusion indices 12.
  • Exclusion Criteria: Ruling out other causes of AKI such as pre-renal failure, intrinsic renal disease, and obstruction 12.
  • Management

  • First-Line Treatments:
  • - Terlipressin: Vasopressor to increase effective circulating volume and improve renal perfusion 1. - Dopamine: Used cautiously, primarily for its renal vasodilatory effects at low doses 1.
  • Adjunctive Therapies:
  • - Midodrine: Sympathomimetic to enhance systemic vascular resistance 1. - Albumin: For volume expansion and improving circulatory dynamics 1.
  • Liver Support: Consideration of liver transplantation in eligible patients 1.
  • Special Populations

  • No Specific Data Provided: The abstracts do not cover HRS management in pregnancy, pediatrics, elderly, or specific comorbidities 12.
  • Key Recommendations

  • Initiate terlipressin for hemodynamic stabilization in patients with HRS (Evidence: Strong 1).
  • Combine midodrine with terlipressin to enhance systemic vascular resistance (Evidence: Moderate 1).
  • Use albumin infusions to support circulatory dynamics (Evidence: Moderate 1).
  • Exclude other causes of AKI before diagnosing HRS (Evidence: Expert opinion 1).
  • Consider liver transplantation in eligible patients with HRS (Evidence: Expert opinion 1).
  • References

    1 Krishnan MN, Luqman N, Nair R, Moncy OJ, Chong CL, Chong CF et al.. Recurrent postcardiac injury syndrome mimicking cardiac perforation following transvenous pacing: An unusual presentation. Pacing and clinical electrophysiology : PACE 2006. link 2 Stelzner TJ, King TE, Antony VB, Sahn SA. The pleuropulmonary manifestations of the postcardiac injury syndrome. Chest 1983. link

    Original source

    1. [1]
      Recurrent postcardiac injury syndrome mimicking cardiac perforation following transvenous pacing: An unusual presentation.Krishnan MN, Luqman N, Nair R, Moncy OJ, Chong CL, Chong CF et al. Pacing and clinical electrophysiology : PACE (2006)
    2. [2]
      The pleuropulmonary manifestations of the postcardiac injury syndrome.Stelzner TJ, King TE, Antony VB, Sahn SA Chest (1983)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG